Industry
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
AbbVie $15 billion senior notes offering
The investment-grade offering comprised seven tranches
Auna $360 million U.S. IPO
We advised Auna on its U.S. IPO and NYSE listing
Trial victory in patent infringement case for Magnolia Medical Technologies
We served as lead trial counsel for Magnolia Medical in an action against its sole competitor
Invacare Corporation $130 Million Convertible Senior Notes Offering
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A offering by Invacare…
Quotient Limited Follow-On Offering
Davis Polk advised the sole underwriter in connection with the SEC-registered follow-on public offering of 4,444,445…
BeiGene, Ltd. Initial Public Offering and NASDAQ Listing
Davis Polk advised the joint book-running managers and representatives of the underwriters in the $182.2 million initial…
Editas Medicine, Inc. $108.6 Million Initial Public Offering
Davis Polk advised the active joint book-running managers and representatives of the underwriters in connection with the …
Novavax, Inc. $300 Million Convertible Senior Notes Offering
Davis Polk acted as special product counsel to the representatives of the initial purchasers in connection with a Rule 144A…
Abbott Acquires Alere
Davis Polk is advising JP Morgan as financial adviser to Alere Inc. in connection with its $5.8 billion acquisition by…
Stryker Acquires Sage Products from Madison Dearborn Partners
Davis Polk is advising JP Morgan as financial adviser to Stryker Corporation in connection with its $2.775 billion…
Biotie acquisition by Acorda
Davis Polk is advising Biotie Therapies Corp. in connection with its combination agreement with Acorda Therapeutics, Inc…
Ardelyx, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers in connection with an $86.2 million SEC-registered follow-on common stock…
Adamas Pharmaceuticals, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers in connection with a $66.1 million SEC-registered common stock offering…